Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 May 28;372(22):2149-50.
doi: 10.1056/NEJMe1505050. Epub 2015 Apr 28.

A new vaccine to prevent herpes zoster

Jeffrey I Cohen  1
Affiliations
Editorial

A new vaccine to prevent herpes zoster

Jeffrey I Cohen. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC; ZOE-50 Study Group. Lal H, et al. N Engl J Med. 2015 May 28;372(22):2087-96. doi: 10.1056/NEJMoa1501184. Epub 2015 Apr 28. N Engl J Med. 2015. PMID: 25916341 Clinical Trial.

References

    1. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–84. - PubMed
    1. Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis. 2012;54:922–8. - PMC - PubMed
    1. Lal H, Cunningham AL, Godeaux O, et al. A trial of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015;xx:xx. - PubMed
    1. Garçon N, Van Mechelen M. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems. Expert Rev Vaccines. 2011;10:471–86. - PubMed
    1. Weinberg A, Zhang JH, Oxman MN, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009;200:1068–77. - PMC - PubMed

Substances